GlobeNewswire Inc.··Pomerantz LlpDisc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud
Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.
IRONsecurities fraudclass action lawsuit